Pfizer/BioNTech vaccine appears effective against mutation in new coronavirus variants -study


  • World
  • Friday, 08 Jan 2021

FILE PHOTO: Vials with a sticker reading, "COVID-19 / Coronavirus vaccine / Injection only" and a medical syringe are seen in front of a displayed Pfizer logo in this illustration taken October 31, 2020. REUTERS/Dado Ruvic

NEW YORK (Reuters) - Pfizer Inc and BioNTech's COVID-19 vaccine appears able to protect against a key mutation in the highly transmissible new variants of the coronavirus discovered in Britain and South Africa, according to a laboratory study conducted by the U.S. drugmaker.

The study by Pfizer and scientists from the University of Texas Medical Branch, which has not yet been peer-reviewed, indicated the vaccine was effective in neutralizing variants with the so-called N501Y mutation, situated on a portion of the virus that it uses to enter and infect cells.

Limited time offer:
Just RM5 per month.

Monthly Plan

RM13.90/month
RM5/month

Billed as RM5/month for the 1st 6 months then RM13.90 thereafters.

Annual Plan

RM12.33/month

Billed as RM148.00/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
   

Next In World

African migrant disaster survivor haunted by weeks lost at sea
Most global tech leaders see their companies unprepared for AI
India's poll panel seeks responses to complaints against Modi, Rahul Gandhi
Russian missile damages civilian, railway infrastructure in Ukraine's Cherkasy region, air force says
Iran's judiciary confirms rapper Toomaj Salehi death sentence
Artificial intelligence offers an opportunity to improve EV batteries
Sails of iconic Paris cabaret club Moulin Rouge fell off overnight
Construction boss accused of bribing Russian minister as scandal widens
What next for TikTok in the US?
North Macedonia's opposition rightist leads ahead of May 8 presidential poll runoff

Others Also Read